Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

Disparities in head and neck cancer: Assessing delay in treatment initiation

(2012) Urjeet A. Patel et al.   LARYNGOSCOPE

Long-term outcome and patterns of failure in patients with advanced head and neck cancer

(2011) Henrik Hauswald et al.   Radiation Oncology

Feasibility, Toxicity, and Efficacy of Short Induction Chemotherapy of Docetaxel Plus Cisplatin or Carboplatin (TP) Followed by Concurrent Chemoradio ­ therapy for Organ Preservation in Advanced Cancer of the Hypopharynx, Larynx, and Base of Tongue

(2011) Sabine Semrau et al.   STRAHLENTHERAPIE UND ONKOLOGIE

HPV status in head and neck tumors

(2010) Felix Glombitza et al.   PATHOLOGY RESEARCH AND PRACTICE

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study

(2009) A. Paccagnella et al.   ANNALS OF ONCOLOGY

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER